ArticleCell regeneration (London, England)2025

Dasatinib demonstrates efficacy in organoid derived paclitaxel-resistant Trp53/Cdh1-deficient mouse gastric adenocarcinoma with peritoneal metastasis.

Wenshuai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.